Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    3 days ago
    Change Detected
    Summary
    No significant changes detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-01T08:10:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Cali, Valle del Cauca Department, Colombia, 760042 to the locations list and removed Santiago de Cali, Valle del Cauca Department, Colombia, 760042.
    Difference
    0.0%
    Check dated 2025-10-25T06:39:37.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    Update the page to v3.2.0 with a government funding notice about potential delays and current operating status for the NIH Clinical Center; remove the old v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-03T08:56:27.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several risk/quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while noting a prior version (v3.0.2).
    Difference
    0.1%
    Check dated 2025-09-26T04:28:57.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Update of geographic names to the new 'Respublika' naming convention and a removal of a 'Back to Top' link.
    Difference
    0.1%
    Check dated 2025-09-18T21:43:41.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Only a version bump from v3.0.0-post.1-g752effb-HEAD to v3.0.2; no substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-11T16:50:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.